文献速递耳科与耳神经

正常听力与感音神经性聋中的血液Prestin水平:范围综述

Blood Prestin Levels in Normal Hearing and in Sensorineural Hearing Loss: A Scoping Review.
PubMed 文献 · Ear Hear · 2021-01-01

本范围综述遵循PRISMA-ScR指南,检索Medline等数据库,纳入7项用ELISA检测啮齿类及人类血液Prestin的研究。结果显示正常听力者也可检出Prestin但正常范围不明;耳蜗损伤后Prestin先升后降,变化程度与听力损失程度、损伤部位及恢复相关,但方法学局限使结论不稳健。

要点

  • 正常听力者血液中可检出Prestin,但正常参考范围尚不明确。
  • 耳蜗损伤后血液Prestin似乎先升高后回落至基线附近或以下。
  • 现有证据因样本量小、随访短等方法学缺陷,尚不足以支撑稳健结论。

核心结论

  • 现有概念验证研究支持研究正常听力与感音神经性聋中的血液Prestin水平,但需更大规模纵向研究。

研究设计与样本

  • 遵循PRISMA-ScR指南的范围综述,检索Medline、Central Scopus、PROSPERO和Clinicaltrials.gov等数据库,不限研究类型,纳入啮齿类与人类中关注正常听力及感音神经性聋血液Prestin水平的研究,并手工检索结果。

主要发现

  • 共纳入7项使用ELISA检测啮齿类与人类血液Prestin的研究,涵盖正常听力及噪声性、药物性或特发性突发性聋。
  • 正常听力受试者循环中可检出Prestin,但正常范围仍不明确。
  • 耳蜗损伤后血液Prestin水平似乎先升高,然后回落至基线附近或以下。
  • Prestin变化程度与受试者听力损失程度、耳蜗损伤区域及恢复情况相关。
  • 血液Prestin水平及其时间变化似乎与耳蜗损伤相关,但方法学弱点(样本量小、表型不详细、混杂因素排除不足、随访短)不允许得出稳健结论。

临床怎么用

  • 血液Prestin有望作为易测量的早期感音神经性聋生物标志物,但当前证据尚不支持临床常规应用。

局限性

  • 纳入研究存在样本量小、缺乏详细表型、混杂因素排除不足和随访时间短等方法学缺陷。
  • 正常听力者的血液Prestin正常范围尚未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Recently, it has been hypothesized that blood prestin concentration levels may reflect cochlear damage and thus serve as an easily measurable, early sensorineural hearing loss (HL) biomarker. This is a scoping review aiming to identify and critically appraise current evidence on prestin blood levels and their temporal variation in rodents and humans with normal hearing and with sensorineural HL. DESIGN: This study was designed and held according to PRISMA Extension for Scoping Reviews (PRISMA-ScR) guidelines. With no limitation with regards to study type, animal and human studies focusing on prestin blood levels in normal hearing and in sensorineural HL were sought in major databases such as Medline, Central Scopus, PROSPERO, and Clinicaltrials.gov. Results were then hand-searched. A data charting form was developed including the parameters of interest. RESULTS: Seven studies focusing on measuring prestin blood levels by means of ELISA in rodents and human subjects with normal hearing and noise-induced, drug-induced, or idiopathic sudden HL were found eligible and were included in the analysis. According to these proof-of-concept studies, prestin can be detected in the circulation of subjects with no HL; however, normal ranges remain unclear. After cochlear damage, blood prestin levels seem to initially rise and then return to near or below baseline. The degree of their change relates with subjects' degree of HL, damaged cochlear region and recovery. Prestin blood levels and their temporal variation seem to correlate with cochlear damage; however, methodological weaknesses, such as small sample size, lack of detailed phenotyping, insufficient exclusion of confounding factors, and short follow-up, do not allow for robust conclusions. CONCLUSIONS: Current findings support the value of studying blood prestin levels in normal hearing and HL and highlight a need for larger-scale longitudinal research.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Iliadou E, Kikidis D, Pastiadis K, et al. Blood Prestin Levels in Normal Hearing and in Sensorineural Hearing Loss: A Scoping Review. Ear Hear. 2021. PMID: 33900207. doi:10.1097/AUD.0000000000001045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。